AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 17,520
-50 (-0.28%)
At close: Sep 9, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 481.96 billion as of September 9, 2026. Its market cap has decreased by -16.25% in one year.
Market Cap
481.96B
Enterprise Value
401.77B
Revenue
725.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
17,520.00
ChartMarket Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 481.96B, an increase of 109.78%. That is a compound annual growth rate of 19.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 481.96B | -62.17% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qurient | 937.32B |
| Rznomics | 785.87B |
| ROKIT Healthcare | 441.05B |
| Curocell | 366.21B |
| Inventage Lab | 356.65B |
| HansBiomed | 279.95B |
| IntoCell | 274.30B |
| S.Biomedics | 235.81B |